Group items tagged

The Department of Health and Social Care (DHSC) has unveiled proposed updates to the NHS Constitution for England, signalling a significant step forward in prioritizing patient privacy, dignity, and safety. At the heart of these reforms lies Martha's Rule, a testament to the power of grassroots advocacy and the enduring legacy of 13-year-old Martha Mills. Martha's Rule, born from the tragic loss of Martha Mills due to a failure in escalating her care, stands as a beacon of hope for future patients and their families. Prompted by Martha's parents' tireless campaign, this rule empowers patients to request intimate care from providers of the same biological sex, ensuring that individual needs are recognized and respected. Additionally, it guarantees the right to a rapid review from an external care team when a patient's condition deteriorates, offering a lifeline in moments of crisis.

The pharmacy regulator can hold hearings and meetings either remotely or in-person in future as the Council of the GPhC has agreed to a change in its rules. The rules are expected to come into force on 1 October 2022. Until the rules and new policy and guidance come into force, the GPhC will continue to only hold remote hearings with the consent of the person concerned and/or their legal representative. Following positive feedback from those taking part in remote hearings, the GPhC consulted on a proposed permanent change to its rules so it could continue to hold hearings remotely in the future, when it is fair and appropriate to do so. The proposal to continue remote hearings, including fitness to practise hearings, received wide support with 78 per cent of respondents agreeing. "During the COVID-19 pandemic lockdown and restrictions we had to hold many meetings and hearings remotely by videolink. As such we were granted - along with other regulators - a temporary provision to enable us to do this and carry out our statutory role," Duncan Rudkin, chief executive of the GPHC, said.

The Department of Health and Social Care (DHSC), led by Victoria Atkins MP and Maria Caulfield MP, has unveiled proposed updates to the NHS Constitution for England, aiming to fortify the principles of privacy, dignity, and safety for all patients. Martha's rule was prompted by a campaign led by the parents of 13-year-old Martha Mills who tragically succumbed to sepsis after staff at King's College Hospital failed to escalate her care to intensive care, despite her family's pleas regarding her worsening condition in 2021. Under the new guidance is the introduction of Martha's Rule, empowering patients to request intimate care from someone of the same biological sex ensuring that the distinct needs of men and women are recognized and addressed. Patients and their loved ones can exercise the right to "access to a rapid review from outside the care team if the patient is deteriorating." The consultation on the proposed updates is set to run for eight weeks, inviting feedback from patients, healthcare professionals, and stakeholders for a review

P3Care investigates the QPP MIPS 2021 proposed rule and how it will impact the healthcare industry. MIPS consulting firms constantly bring reimbursements.

P3Care investigates the QPP MIPS 2021 proposed rule and how it will impact the healthcare industry. MIPS consulting firms constantly bring reimbursements.

Health secretary Sajid Javid said on Monday (December 6) there is now community transmission of the Omicron variant of the coronavirus across regions of England but it is too early to say if this will "knock us off our road to recovery". Defending the introduction of stricter rules to slow the spread of the virus, Javid told parliament that the government was "leaving nothing to chance" while scientists assessed the variant, which was first reported in South Africa last month. Javid said there are now 261 Omicron cases in England, 71 in Scotland and four in Wales - a total of 336. "This includes cases with no links to international travel, so we can conclude there is now community transmission across multiple regions of England," Javid said. Prime minister Boris Johnson said on Monday no further restrictions were currently needed to deal with the Omicron variant, but refused to rule out imposing such measures before Christmas.

Drugmakers GSK, Pfizer, Sanofi and Boehringer Ingelheim on Tuesday were spared thousands of US lawsuits claiming that the heartburn drug Zantac caused cancer, as a judge found the claims were not backed by sound science. The ruling by US District Judge Robin Rosenberg in West Palm Beach, Florida, knocks out about 50,000 claims in federal court, though it does not directly affect tens of thousands of similar cases pending in state courts around the country. "We are extremely surprised by this miscarriage of justice," and "fully expect" the ruling will be reversed on appeal, lawyers for the plaintiffs said in a joint statement. A Sanofi spokesperson said the decision "significantly decreases the scope of the litigation potentially by over 50 per cent," with the remaining litigation being only in state court. A spokesperson for GSK said the company welcomed the decision and Pfizer said it was pleased by the outcome. Privately-held German drugmaker Boehringer said in a statement that it looked forward to "continuing our vigorous defense of the remaining cases in state courts."

Cutting the red tape that blocks pharmacists to alter the HRT prescription could 'quickly fix' the problem of women unable to access their HRT medicines, the Royal Pharmaceutical Society (RPS) told Daily Mail. RPS has suggested that allowing pharmacists to prescribe alternative HRT treatment amid nationwide shortage of HRT medicine could help the women who are struggling to access these medicines. Thorrun Govind, chair of the English Pharmacy Board, told MailOnline 'changes in prescription rules need to be changed urgently.' She added, 'For the pharmacists on the ground, they need the ability to get rid of this bureaucracy. When you think about it - who's best able to offer an alternative - that tends to be the pharmacist.' MailOnline quoted Professor Claire Anderson, president of the Royal Pharmaceutical Society, as said, 'We welcome the Health Secretary meeting with key suppliers and manufacturers to find solutions to the current shortages. But cutting the red tape holding pharmacists back could provide a 'quick fix' that would allow 'women to access their HRT medicines more speedily'.

The Drug Enforcement Administration is changing regulation for prescribing controlled substances via telemedicine. Here's what medical professionals need to know about the adjustments to these policies. Read more: https://www.hospitalrecruiting.com/blog/8673/the-dea-telemed-prescription-rules-are-here-to-stay/?utm_source=social_media&utm_medium=blog&utm_campaign=social_posting #dea #telemedicine #healthcare #medicalnews #physician #doctor #healthcarenews

The Office for Civil Rights (OCR) at the U.S. Department of Health and Human Services has announced relaxation in HIPAA rules for covered entities and business associates who participate in good faith in the COVID-19 testing site operation. It doesn't stop there, but HIPAA penalties won't apply to covered healthcare providers for practicing telehealth medicine using third-party applications such as Skype or Facebook Messenger

The Office for Civil Rights (OCR) at the U.S. Department of Health and Human Services has announced relaxation in HIPAA rules for covered entities and business associates who participate in good faith in the COVID-19 testing site operation.

CMS expects eligible clinicians to perform well in MIPS QPP. Sometimes despite the efforts, physicians are unable to meet even the minimum performance threshold. We can't blame them if they happen to suffer from unexpected hardships such as severe weather conditions or other unfavorable situations.

CMS expects eligible clinicians to perform well in MIPS QPP. Sometimes despite the efforts, physicians are unable to meet even the minimum performance threshold. We can't blame them if they happen to suffer from unexpected hardships such as severe weather conditions or other unfavorable situations. CMS offers relaxation for such cases.

The minimum Covid-19 self-isolation period in England will be cut to five days from seven if someone tests negative twice, health secretary Sajid Javid said on Thursday (January 13) - a move that could reduce staffing disruption in businesses and infrastructure. The rapid spread of the Omicron variant has fuelled a spike in Covid-19 cases to record highs in Britain, and the surge has cause major disruption to the staffing of hospitals, schools and transport as staff have to self-isolate. "We've made the decision to reduce the minimum self-isolation period to five full days in England," Javid told parliament. "From Monday, people can test twice before they go, leaving isolation at the start of day six." The government had previously reduced isolation period to seven days from 10 days to people in England who get a negative result on a rapid lateral flow test two days in a row.

While Northern Irish business groups has welcomed the certainty a new EU-UK deal on post-Brexit trade rules for the region provided, the pharmaceutical industry too has expressed cautious optimism. In his speech on the Windsor Framework on Monday (February 28) Prime Minister Rishi Sunak said the agreement "delivers a landmark settlement on medicines". "From now on, drugs approved for use by the UK's medicines regulator will be automatically available in every pharmacy and hospital in Northern Ireland," he announced. The National Pharmacy Association's Northern Ireland manager Anne McAlister expressed a sense of cautious optimism. She said: "While the devil may yet be in the detail, the Windsor Framework would appear to be good news for pharmacies in Northern Ireland. It seems to address the main concerns we have expressed about medicines supplies to NI, but we want to examine the small print to ensure the new arrangements meet the needs of our members and the patients they serve.

The Pharmacists' Defence Association (PDA) has undertaken an additional survey of pharmacists employed in the NHS, before deciding to hold their first-ever ballot for industrial action. The PDA has more than 7,000 NHS-employed pharmacists in membership and the union is actively considering balloting those members regarding strike action. The association said: "The experience of some other unions has shown that the government's restrictive rules, designed to make it difficult for working people to lawfully take industrial action, means trade unions should test members' strength of feeling before balloting." "Trade unions are not only forced to rely upon postal ballots, but for lawful industrial action to be taken, the result must also meet three tests- at least 50% of eligible voters must vote; at least 40% of eligible voters must vote 'yes' and a majority of votes must be for 'yes'." The association is asking members in England, Northern Ireland and, Wales to show if their collective wish, insignificant enough strength, is for strike action. PDA has emailed the survey to all its members in the NHS in the three nations and will close on Tuesday 3 January.

The realm of fashion is usually ruled by the women, but is incomplete without the men. Men's fashion has now reached next level and they too do not wish to lag regarding looks, clothes and even accessories. We are sure that you would not like to miss on the top fashion bloggers of India and these sought after Instagram influencers.

P3Care, being a proud part of the healthcare industry, always tries to educate its audience with the latest and authenticated information. Today, we are bringing up the topic of how to protect everyone around us.

...there are layers of telehealth program development to unpack. Core considerations for rural telehealth program development include: state telemedicine rules and regulations, language and terminology, state parity laws, staffing and teleconsultation models, funding, broadband access, and benefits to rural communities.

The current circumstances are evolving at an exponential pace. Trying to accomplish superhuman feats using outmoded systems and procedures will only lead to frustration. Don't be afraid to bend the rules. Challenge the established paradigms and create new avenues, methods, procedures, tactics, and strategies that can be rapidly deployed to meet the demand head-on.

The General Pharmaceutical Council (GPhC) has launched a consultation on whether people agree or disagree that its hearings should continue to be held remotely when it is fair and practical to do so. The 12-week consultation - which ends on February 8 - seeks views on a proposed permanent change to the GPhC's procedural rules which will allow it to conduct hearings and meetings by teleconference or videolink. The pharmacy regulator is seeking changes to enable it to continue to hold some hearings remotely in the future following positive feedback from those taking part in hearings during the Covid-19 pandemic which the GPhC held remotely by videolink. "In cases where the GPhC investigates a concern about a pharmacist or pharmacy technician and decides there is evidence to show that their fitness to practise may be impaired, the case may need to be referred for a hearing before a committee," GPhC said in a statement today (November 16).

A new study has shown that Covid-19 can spread between unmasked people at a distance of more than two metres even outdoors. A team of engineers from the University of Cambridge used computer modelling to quantify how droplets spread when people cough. They found that the two-metre rule was arbitrary and that social distancing alone was not enough to stop the spread of the virus. The team also found that individual coughs vary widely, and that the 'safe' distance could have been set at anywhere between one to three or more metres. The results, published in the journal Physics of Fluids, suggest that social distancing is not an effective mitigation measure on its own, and underline the importance of vaccination, ventilation and masks.

A Nottingham-based pharmacist has been struck off the General Pharmaceutical Council (GPhC) register for bringing "the profession into to disrepute" by stealing hundreds of thousands of pounds in a bid to settle his gambling debt. Peter Sameh Saad (33) spun a web of lies and duped a friend out of more than half a million pounds to fund his addiction and pretended he had "serious if not terminal" testicular cancer. "It is difficult to imagine a more heinous fraud than one predicated on feigning a cancer diagnosis", a GPC panel ruled. Saad committed three frauds on a total of £536,689.95 between September 2018 and May 2019. First, he tricked a friend, whom he knew through his local church, into sending him around £288,200 by claiming that his newly-purchased pharmacy in US was "seized" by the authorities over visa issues and that he "had some difficulty making the mortgage payments". Later Saad conned the same friend, named only as 'Person A' in court documents, into sending him a total of £127,150 by lying about a non-existent cancer diagnosis and private treatment. Finally, he extracted a further £121,339.95 from an investments and credit group (named Company A) of which his friend was chief executive after inviting him to set up a 'pharmaceutical warehouse', a plan that "impressed Person A and he agreed to invest in the business."